Table 3.
Median (P50) and Interquartile range (IQR) of indicators in four half-years from July 1, 2017 to June 30, 2019 for IBW-class 2 (n = 610, UDD used daily doses, FP finishing pig place)
| Indicator | 2017–2 | 2018–1 | 2018–2 | 2019–1 | ||||
|---|---|---|---|---|---|---|---|---|
| P50 | IQR | P50 | IQR | P50 | IQR | P50 | IQR | |
| Mortality [%] | 2.38 | 1.60 | 2.26 | 1.45 | 2.37 | 1.59 | 2.40 | 1.75 |
| Average daily gain [g] | 856 | 85 | 850 | 95 | 852 | 69 | 860 | 105 |
| Feed conversion ratio [kg/kg] | 2.81 | 0.20 | 2.80 | 0.26 | 2.81 | 0.24 | 2.77 | 0.30 |
| Treatment frequency [UDD/FP] | 0.72 | 2.90 | 0.49 | 2.92 | 0.55 | 3.12 | 0.46 | 2.61 |
| Pneumonia [%] | 10.74 | 8.91 | 10.34 | 9.26 | 8.52 | 8.90 | 9.64 | 11.33 |
| Pleurisy [%] | 4.54 | 7.44 | 4.15 | 8.58 | 3.74 | 5.52 | 4.50 | 8.99 |
| Pericarditis [%] | 3.00 | 2.26 | 2.97 | 2.76 | 3.15 | 2.69 | 3.92 | 2.93 |
| Arthritis [%] | 0.55 | 0.65 | 0.50 | 0.60 | 0.66 | 0.86 | 0.40 | 0.61 |
| Abscess [%] | 0.87 | 0.67 | 0.79 | 0.62 | 0.92 | 0.82 | 0.90 | 0.82 |
| Ear lesions [%] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Tail lesions [%] | 0.42 | 0.79 | 0.37 | 0.73 | 0.54 | 1.03 | 0.57 | 1.03 |
| Dermal alterations [%] | 0.07 | 0.20 | 0.12 | 0.28 | 0.15 | 0.22 | 0.08 | 0.20 |
| Bursitis [%] | 0.45 | 0.69 | 0.29 | 0.51 | 0.60 | 0.72 | 0.58 | 0.87 |
| Liver milk spots [%] | 3.89 | 6.08 | 3.40 | 4.62 | 3.51 | 5.79 | 3.16 | 5.28 |
| Dermal damage [%] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intestinal alteration [%] | 0.47 | 0.58 | 0.45 | 0.64 | 0.38 | 0.59 | 0.27 | 0.62 |
| Whole carcass condemnation [%] | 0.09 | 0.20 | 0.13 | 0.25 | 0.11 | 0.23 | 0.08 | 0.16 |